An act to amend the public health law, in relation to authorizing and establishing a training program for paramedics for the administration of buprenorphine
buprenorphine
A.2253 (Rosenthal)
February 14, 2025
CoOP: Integrative buprenorphine delivery – Increasing treatment access and quality to address Maryland’s overdose epidemic (powerpoint)
Integrating buprenorphine prescribing into OTP
Poster of same model.
Association of Take-Home Naloxone and Opioid Overdose Reversals Performed by Patients in an Opioid Treatment Program
These findings suggest that take-home naloxone supplied to patients in opioid treatment programs may be part of a targeted harm-reduction strategy to reduce negative outcomes associated with opioid overdose in the community.
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
Innovative service modifications to adapt to COVID-19 circumstances primarily involved expanded use of telehealth services (e.g., telemedicine visits for buprenorphine, virtual individual or group therapy sessions, provision of donated or publicly available phones), increased take-home medication allowances for methadone and buprenorphine, expanded uptake of long-acting opioid medications (e.g. extended-release buprenorphine and naltrexone), home delivery of services (e.g. MOUD, naloxone and urine drug screening), outreach and makeshift services for delivering MOUD and naloxone, and provision of a safe supply of opioids.
A942 (Rosenthal)
Last Revised: August 23, 2024
Published: May 7, 2024
Published: May 7, 2024
An act to amend the public health law, in relation to authorizing and establishing a training program for paramedics for the administration of buprenorphine
